Pain Management Devices Market Share Study by Industry Size, Growth Prospects, Revenue Generation and Vendors

 Market Insights

Market focused reports linked with the information and healthcare industry have been recently available by Market Research Future, which issues report on this industry. The global Pain Management Devices Market Share is set to inflate positively at a CAGR of 6.0% during the forecast period (2018–2023).

 Pain is related to clinical, social, and economic burden communities across the world, whereas chronic pain is associated with various health conditions. Therefore, the increasing prevalence of pain pushes the demand for advanced diagnosis and treatment. Pain management offers a 360-degree view of the activities being carried out on various pain conditions. Activities such as pain therapy, medicinal therapy, physiotherapy, exercise, and more come under the preview of the pain management system. The changing healthcare sector has encouraged the pain management market to a great extent.

 Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/1504

 Market Drivers & Trends

The global pain management market is mainly driven by increasing technological advancements, which is expected to expand exponentially in the years to come. Apart from this, the increasing occurrences of chronic pain conditions are also continuously motivating marketers to introduce more technologically advanced products, which, in turn, is bolstering the market at a rapid pace. In this support a new non-invasive neuromodulation device, Stimpod NMS460 was introduced by the Xavant Technology for the treatment of chronic intractable pain. The device received an FDA approval on August 01, 2017.

 On the other hand, various other factors such as mounting geriatric population, improved reimbursement policies in developed countries, the growing prevalence of cancer pain, developing regulatory framework, increase in funding for research, unmet medical needs, rising competition among key players, and growing government aid are uninterruptedly helping in the development of the global pain management market.

 Regardless of these drivers, on the flip side, the existence of some issues associated with the pain management market such as high cost of technology, lack of skilled or trained physicians, and weak healthcare system in low and middle-income countries could act as a hamper to the growth of the global pain management market.

 Key Players

Abbott Laboratories, Abbvie, Allergan, Astellas Pharma, AstraZeneca plc, Bayer AG, Codman And Shurtleff, Inc, DJO Global LLC, Eli Lilly & Company, Endo Health Solutions, F. Hoffmann-La Roche Ltd, Forest Laboratories, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Mallinckrodt plc, Medtronic PLC, ST. Jude Medical, Inc., Boston Scientific Corporation, Pfizer Inc., Halyard Health, Inc., Smiths Medical, B. Braun Melsungen AG, Neurotech Na, Inc., Becton, Dickinson and Company, Nevro Corp., Merck & Co. Inc., Novartis AG, Purdue Pharma LP, Sanofi, Stryker Corporation, Teva Pharmaceuticals, and others are some of the best players in the global pain management market.

 Market Segmentation

The segmentation of the global pain management market is carried out on the basis of the type of pain management devices, type of pain management drugs, indication, mode of purchase, and end-user.

 By type of pain management devices: neurostimulation devices, analgesic infusion pumps, and ablation devices are the segments, out of which neurostimulation devices are further segmented into Transcutaneous Electrical Nerve Stimulation (TENS) devices and Spinal Cord Stimulation (SCS) devices. Ablation devices are also segmented into RF ablation devices and cryoablation devices.

 By type of pain management drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), anticonvulsants, anesthetics, opioids, antimigraine agents, antidepressants, and others are the segments. Among them, the opioids segment is also classified as oxycodone, hydrocodone, tramadol, morphine, codeine, fentanyl, meperidine, methadone, and others.

 By indication: neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, fibromyalgia, chronic back pain, arthritic pain, migraine, post-operative pain, and others are the segments.

 By mode of purchase: counter and prescription-based are the segments.

By end-user: hospitals and clinics, pharmaceutical companies, medical device companies, research and academic institutes, and others are the segments.

 Regional Market Outlook

The Americas leads in the pain management market due to the growing occurrence of chronic pain, well-developed technology, high healthcare expenditure, and the existence of leading players. In the study, according to a study published in the Drug and Alcohol Dependence Journal in 2017, more than 100 million adult Americans suffer from chronic pain. Types of pain, such as chronic low back pain and headaches, are the most common conditions that are diagnosed. Moreover, these conditions are more found in women than men, which states 34.3% in women and 26.7% in men in the United States.

 Europe owes to be in the second position in the market pf pain management with an increasing contribution towards research and development as well as swelling competition among marketers are likely to drive the European pain management market profoundly.

Whereas, the Asia Pacific is the fastest growing pain management market due to the vast patient pool, increasing demand for treatments, and rising healthcare expenditure.

 In this study, according to the data proposed by the Australian Institute of Health and Welfare through 2015 to 2016, the total health expenditure was approximately USD 170.4 billion, i.e., which is 3.6% higher than the investment of 2014 to 2015. Lastly, the Middle East and Africa have the lowest share of the global pain management market owing to diminutive development, lack of technical knowledge, and inadequate medical facilities.

Browse Table of Content with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/pain-management-devices-market-1504 

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Sports Medicine Market Global Analysis, Research, Review, Applications and Forecast

  Global Sports Medicine Market – Overview Sport medicines is a medical branch which deals with the treatment, prevention, and diagnosis of the injuries of the athletes. Sports medicines plays an important part in the sports. Many drivers and restrains affects the growth of the market during the forecast period. Increasing prevalence of sports injuries, increasing number of sports medicine associations, rising awareness alongside of the technological development are the major drivers for the market. From last couple of decades, more people are attracted towards different sports. Increasing awareness about fitness made people from different age groups to participate and join different sports clubs. This lead to more frequent sports injuries. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/3503 According to the Centers for Disease Control and Prevention, on an average about 8.6 million sports and recreation related injuries episodes were reported in 2016. Mor...
Read more

Superdisintegrants Market Analysis And Demand With Forecast Overview

  Market Insights Oral administration of medical drugs in the form of tablets and capsules is one of the most commonly prescribed methods for drug delivery due to several key factors ranging from being easy to swallow to better chemical stability in this form. Superdisintegrants have become a vital addition to tablets and capsules as they facilitate rapid disintegration of smaller doses than conventional disintegrants making them ideal for various medical applications in the pharmaceutical sector. Market Research Future's new publication on the global superdisintegrants market has observed the growth of the market at a healthy CAGR of 7.9% during the forecast period from 2018 to 2023. At the beginning of the forecast period in 2017, the market generated a revenue of USD 371.3 Mn. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/6663 The projected rate of growth is anticipated to establish the market at a value of USD 576.2 Mn by the end of the review period ...
Read more

Inflammatory Bowel Disease Treatment Market Forecast with Trends, Inflammatory Bowel Disease Treatment Market Forecast Share, Industry Size, Opportunities, Analysis and Forecast 

  The inflammatory bowel disease treatment market is expected to register a CAGR of 2.5% during the forecast period due to the increasing patient pool, advances in medical technology, government initiatives for research on novel drugs discovery, and increasing prevalence of anxiety and depression. Moreover, the increasing number of drugs in clinical trials and the growing popularity of prebiotic and probiotic foods are likely to result in market growth. However, high capital investments required for the discovery of drugs, the unsatisfactory effectiveness of treatments, and stringent drug regulatory policies are restraining the growth of the inflammatory bowel disease treatment market. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/6266 Regional Analysis The Americas is expected to be the largest market for inflammatory bowel disease treatment owing to the increasing prevalence of anxiety and rising incidences of ulcerative colitis and Crohn’s disease. The...
Read more